EUVIMEDOpdag EUVIMED
Crossref

Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases

Xinyuan Liu, Huiwen Xue, Karin Wirdefeldt, Huan Song iD, Karin Smedby iD, Fang Fang, Qianwei Liu

Journal of Internal Medicine · 2024

DOI: 10.1111/joim.20001 ↗

At a glance

Journal article in Journal of Internal Medicine, 2024. Written by Xinyuan Liu and 6 co-authors. Institution: Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), State Key Laboratory of Genetic Engineering, …. Major MEDLINE topics: Neurodegenerative Diseases, Clonal Hematopoiesis. Cited 29 times so far (Crossref); 18 references. Funded by: Initial Founding for High Level Talented Scholars in Nanfang Hospital, Southern Medical University, Swedish Research Council (JPND).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Little is known regarding the association between clonal hematopoiesis of indeterminate potential (CHIP) and risk of neurodegenerative diseases.

Objective

To estimate the risk of neurodegenerative diseases among individuals with CHIP.

Methods

We conducted a community‐based cohort study based on UK Biobank and used Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of any neurodegenerative disease, subtypes of neurodegenerative diseases (including primary neurodegenerative diseases, vascular neurodegenerative diseases, and other neurodegenerative diseases), and specific diagnoses of neurodegenerative diseases (i.e., amyotrophic lateral sclerosis [ALS], Alzheimer's disease [AD], and Parkinson's disease [PD]) associated with CHIP.

Results

We identified 14,440 individuals with CHIP and 450,907 individuals without CHIP. Individuals with CHIP had an increased risk of any neurodegenerative disease (HR 1.10, 95% CI: 1.01–1.19). We also observed a statistically significantly increased risk for vascular neurodegenerative diseases (HR 1.31, 95% CI 1.05–1.63) and ALS (HR 1.50, 95% CI 1.05–2.15). An increased risk was also noted for other neurodegenerative diseases (HR 1.13, 95% CI 0.97–1.32), although not statistically significant. Null association was noted for primary neurodegenerative diseases (HR 1.06, 95% CI 0.96–1.17), AD (HR 1.04, 95% CI 0.88–1.23), and PD (HR 1.02, 95% CI 0.86–1.21). The risk increase in any neurodegenerative disease was mainly observed for DNMT3A ‐mutant CHIP, ASXL1 ‐mutant CHIP, or SRSF2 ‐mutant CHIP.

Conclusion

Individuals with CHIP were at an increased risk of neurodegenerative diseases, primarily vascular neurodegenerative diseases and ALS, but potentially also other neurodegenerative diseases. These findings suggest potential shared mechanisms between CHIP and neurodegenerative diseases.

Subjects

MeSH terms (MEDLINE)

Neurodegenerative DiseasesClonal HematopoiesisHumansFemaleMaleMiddle AgedAgedRisk FactorsDNA Methyltransferase 3AUnited KingdomCohort StudiesDNA (Cytosine-5-)-MethyltransferasesRepressor ProteinsAmyotrophic Lateral SclerosisParkinson DiseaseDNA-Binding ProteinsDioxygenases

Author keywords

amyotrophic lateral sclerosisclonal hematopoiesis of indeterminate potentialcohort studyneurodegenerative diseases

Substances

DNA Methyltransferase 3ADNMT3A protein, humanASXL1 protein, humanDNA (Cytosine-5-)-MethyltransferasesRepressor ProteinsTET2 protein, humanDNA-Binding ProteinsDioxygenases

Authors and institutions

  • Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), State Key Laboratory of Genetic Engineering, Center for Evolutionary Biology, School of Life Sciences, Fudan Univer…
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.
  • Department of Medical Epidemiology and Biostatistics and Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
  • Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

ORCID profiles: Huan Song, Karin Smedby

Funding

  • Initial Founding for High Level Talented Scholars in Nanfang Hospital
  • Southern Medical University
  • Swedish Research Council (JPND)
  • Initial Founding for Postdoc in Greater Bay Area Institute of Precision Medicine (Guangzhou)

Cite

APA

Liu, X., Xue, H., Wirdefeldt, K., Song, H., Smedby, K., Fang, F., & Liu, Q. (2024). Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases. Journal of Internal Medicine. https://doi.org/10.1111/joim.20001

Vancouver

Liu X, Xue H, Wirdefeldt K, Song H, Smedby K, Fang F, et al. Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases. Journal of Internal Medicine. 2024. doi:10.1111/joim.20001

BibTeX
@article{Liu2024,
  author = {Liu, Xinyuan and Xue, Huiwen and Wirdefeldt, Karin and Song, Huan and Smedby, Karin and Fang, Fang and Liu, Qianwei},
  title = {Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases},
  journal = {Journal of Internal Medicine},
  year = {2024},
  doi = {10.1111/joim.20001}
}
Start for free →